ABSTRACT The effect of medical and surgical treatment on subsequent sudden cardiac death was assessed in 13,476 patients in the Coronary Artery Surgery Study registry who had significant coronary artery disease, operable vessels, and no significant valvular disease. (Patients were assigned to medical or surgical therapy on the basis of clinical judgment and not according to a randomization scheme; therefore, biases associated with unknown variables could not be evaluated.) Sudden cardiac death occurred in 452 patients (3.4%) during a mean follow-up of 4.6 years. Five year survival free of sudden death for medically treated patients was 94 ± 0.3%, and that for surgically treated patients was 98 + 0.2% (p < .0001). Twelve baseline clinical, electrocardiographic, and angiographic variables were significantly different between patients alive at the last follow-up and those suffering sudden death. Data on these variables were available for 11,508 patients. Sudden death occurred in 257 (4.9%) of 5258 medically treated and 101 (1 6%) of 6250 surgically treated patients. In a high-risk patient subset with three-vessel disease and history of congestive heart failure, 91% of surgically treated patients had not suffered sudden death compared with 69% of medically treated patients. After Cox survival analysis was used to correct for baseline variables, surgical treatment had an independent effect on sudden death (p < .0001). This reduction was most pronounced in high-risk patients.
SUDDEN CARDIAC DEATH is a major health problem, with approximately 400,000 deaths per year in the United States." 2 Information on the clinical setting and mechanism has been obtained from autopsy series, coronary care units, and patients resuscitated after outof-hospital arrest. Patients at increased risk can be identified by clinical features and angiographic findings. 5 1-21 Although ventricular arrhythmias are the usual mechanism,'6 22, 23 the initiating events remain unknown.2F In some patients, the arrhythmia may result from ischemia. If ischemia is important, coronary artery bypass grafting (CABG) could potentially play an important role and may reduce the incidence of sudden cardiac death.
Previous studies on the role of CABG for prevention of sudden cardiac death have suggested a benefit from THERAPY AND PREVENTION-cORONARY ARTERY DISEASE
The vital status as of December 1982 was known for 98% of the initially enrolled 20,270 patients: 98.1 % of medically and 98.9% of surgically treated patients. The purpose of this study was to evaluate the effect of medical and surgical therapy on sudden cardiac death. We did not analyze the effect of medical and surgical therapy on all causes of death; this is the topic of forthcoming studies. The analysis is restricted to patients with significant CAD and operable vessels but no significant valvular heart disease at the time of initial angiography.
Definitions Sudden cardiac death. Sudden cardiac death is defined as the sudden occurrence of death within 1 hr after the onset of symptoms and generally before the availability of medical attention. The circumstances under which death occurred were specified whenever possible. Sudden deaths were classified as occurring at home, at work, during recreational activity, in the hospital, or en route to the hospital. Sudden deaths were further classified as witnessed or unwitnessed. The definition of unwitnessed sudden cardiac death is difficult. A subcommittee of the steering committee of CASS reviewed all deaths of the randomized patients and categorized them as sudden death, nonsudden cardiac death, and noncardiac death. Unwitnessed sudden cardiac death was thought to have occurred when the patient was alive and well when last seen and soon after was discovered to be dead (for example, during sleep). In this study, 23 patients died suddenly within 30 days after cardiac operation; their deaths were considered cases of perioperative mortality and not sudden deaths.
Coronary artery disease. Significant CAD was defined as 70% or more luminal diameter narrowing of the right coronary artery or of the left anterior descending or circumflex coronary arteries or their major branches or as 50% or more stenosis of the left main coronary artery. In a patient with a dominant right or balanced coronary artery system, significant stenosis of the left main coronary artery was coded as two-vessel disease; in a patient with a dominant left coronary artery, significant stenosis of the left main coronary artery was coded as three-vessel disease. Congestive heartfailure (CHF) score. CHF was graded from 0 (no CHF) to 4 (severe CHF). This score is a count of four items: a history of CHF, the presence of pulmonary rales at baseline, the use of digitalis, and the use of diuretics at baseline.
Functional impairment due to CHF was assessed with a score ranging from 0 (no CHF) to 5 (symptoms of severe CHF).
Statistical analysis. Statistical comparisons between groups were performed by use of t test analysis for continuous variables and x2 analysis for discrete variables. Differences in the rates of sudden death between medically and surgically treated patients were tested by the log-rank test on the basis of the entire followup experience. 32 34 Patients who died from other causes were included in the group at risk for sudden death up to the time of death.
Medically treated patients were those who did not undergo operation or those who underwent operation late in the study period. Surgically treated patients were those who had CABG during hospitalization at their enrolling institution, when 95% of patients have surgery. The number of days after enrollment within which 95% of the operations were performed was determined for each hospital (average time, 4 months). At each hospital, patients who had an operation during this period, or within 90 days if this period was less than 90 days, were excluded from the medical group. Survival time was counted from the average days to operation for the hospital where the patient was enrolled.33 (Eleven medically treated patients had sudden death within 30 days after this point; these patients were included.) Patients who died before this cutoff were excluded from the analysis. This type of analysis removes the unfair bias of early deaths attributed to medical therapy in patients who may have been assigned to undergo operation.33
Cox regression analysis of the time to sudden cardiac death was used to adjust the comparison of medically and surgically treated patients for covariates. For the medically treated patients alone, five variables were selected by stepwise analysis of the time to sudden death from a group of 36 potential covariates (table 1) . These variables and the coefficients estimated by the Cox analysis were used to construct a linear index of risk. The index was used to separate patients into quartiles ranging from low to high risk (see Appendix). Medically and surgically treated patients were compared within quartiles.
Both medically and surgically treated patients were included in a second stepwise Cox analysis using the same 36 covariates. The effect of operation on the time to sudden cardiac death was assessed by adding a variable for operation at the final step and testing that its coefficient was significantly different from zero. The relative risk of sudden death for patients undergoing CABG was estimated by exp (b), where b is the coefficient estimated by the Cox analysis for the therapy covariate.32 Results
Comparison of patients suffering sudden cardiac death with those alive at follow-up. There were 13,476 patients The effect of CABG on sudden cardiac death was analyzed in patients with witnessed and those with unwitnessed sudden cardiac death to determine whether there was a differential effect in these two groups. For witnessed sudden death, the 5 year survival free of sudden death was 99 ± 0. 1 % for surgically treated patients and 96 ± 0.3% for medically treated patients. Results were similar for patients suffering unwitnessed death, in whom the 5 year survival free of nonsudden death was 99 ± 0. 1 % for surgically treated patients and 98 ± 0.2% for medically treated patients.
The effect of CABG on reduction in sudden cardiac death was dependent on the patient subset analyzed. In patients at low risk for the development of sudden cardiac death (for example, one-or two-vessel disease and no CHF), although there was a statistically significant difference, actual differences in incidence of sudden death at 5 years of follow-up between the medically and surgically treated groups (figure 2, A and B) were too small to be of clinical help. Among the patients with three-vessel disease and no CHF there was both a statistically significant and a clinical difference: 98% of patients treated surgically had not suffered sudden cardiac death, whereas 92% of the patients treated medically had not suffered sudden cardiac death ( figure 2, C) . The biggest effect of CABG, however, was noted in patients with two-or three-vessel disease and a history of CHF ( figure 3, A and B) . In CIRCULATION patients with three-vessel disease and a history of CHF, 91% of the patients treated surgically were alive, whereas 69% of the patients treated medically were alive.
Cox survival analysis. Data on all variables (see Appendix) were available for 6250 surgically treated patients and 5258 medically treated patients. These 11 ,508 patients were analyzed to assess the incidence of sudden cardiac death and the effect of CABG on sudden cardiac death. Patients were separated into quartiles based on the risk of sudden cardiac death as determined by Cox survival analysis. In each quartile, cumulative survival curves were then computed for medically and surgically treated patients (figure 4). The difference in the incidence of sudden cardiac death between the medically and surgically treated patients increased with the risk quartile. In the lowest-risk quartile, the incidence of sudden cardiac death at 5 years of follow-up was similar for the medically (1 %) and surgically (0%) treated patients (p = .08). In the Relief or reduction of ischemia by CABG may have been the underlying reason for the decrease in sudden cardiac death in our surgically treated patients. In these patients, a reasonable hypothesis is that the relief of ischemia by CABG may have reduced or eliminated the acute precipitating or triggering event and thereby decreased the incidence of sudden cardiac death.
The role of operation in the prevention of sudden cardiac death remains to be determined. The incidence of sudden cardiac death in the large population of patients with CAD is low. Efforts must continue to identify patients at significantly increased risk. In patients at very high risk for sudden cardiac death (for example, those with out-of-hospital cardiac arrest), surgical therapy may offer considerable promise. In other subsets (for example, patients with three-vessel disease and left ventricular impairment), surgical intervention may also be considered in an effort to decrease the incidence of subsequent sudden cardiac death. Appendix Baseline variables included in the Cox stepwise survival analyses of sudden cardiac death were sex; history of hypertension, diabetes, myocardial infarction, or cardiac arrest; symptoms of rhythm disturbance; angina; unstable angina; severity of angina; use of antiarrhythmic drugs, f3-adrenergic blockers, digitalis, or diuretics; right or left coronary dominance; percentage of stenosis of the left main coronary artery or of the proximal left anterior descending artery; electrocardiographic evidence of premature ventricular contraction or of infarction; QRS duration; electrocardiographic evidence of any abnormality or of arrhythmia; Q waves; T wave abnormality; ST depression; ST elevation; left ventricular score29 31; presence of aneurysm; number of diseased vessels; amount of myocardium at jeopardy; number of operable vessels; age; history of CHF; impairment due to CHF; CHF score; number of noncardiac illnesses; and occupation.
The variables selected by use of data from medically treated patients only are given in table 1. The risk index was obtained by multiplying each covariate by its coefficient, and the resulting five numbers were summed. The constant 3.0544 was subtracted to normalize the equation so that an average patient in this population had a risk index equal to zero. The quartiles of risk were determined by the cutpoints 0.55, 0.18, and 0.78.
The fit of the Cox model was tested by restricting the data set to a randomly selected two-thirds of the total population. A stepwise Cox survival analysis was used on this subset to construct a linear index of risk on the basis of the selected covar- iates. The remaining one-third of the population was separated into quintiles on the basis of the derived risk index, and the Cox model estimate of the survival curve during 7 years was estimated for each quintile. In each quintile, the estimate was calculated by use of the average value of the model covariates in that quintile. The Cox model estimate in each quintile was within a 95% confidence band for the corresponding life table estimate.)4 This was evidence that the Cox proportional-hazards model is an appropriate model for the observed data.
